Significance of SARS-CoV-2 Specific Antibody Testing during COVID-19 Vaccine Allocation

Akane B. Fujimoto, Inci Yildirim, Pinar Keskinocak
doi: https://doi.org/10.1101/2021.01.28.21250721

Data Availability

Only publicly available data has been used for this paper and it is cited in the manuscript.

Back to top
Posted February 01, 2021.
Download PDF

Supplementary Material

Data/Code
Email
Significance of SARS-CoV-2 Specific Antibody Testing during COVID-19 Vaccine Allocation
Akane B. Fujimoto, Inci Yildirim, Pinar Keskinocak
medRxiv 2021.01.28.21250721; doi: https://doi.org/10.1101/2021.01.28.21250721
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area